5,7-Diiodo-8-Quinolinol - CAS 83-73-8
Catalog number: 83-73-8
Category: Inhibitor
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Molecular Formula:
C9H5NOI2
Molecular Weight:
396.95
COA:
Inquire
Targets:
Others
Description:
5,7-Diiodo-8-Quinolinol is a topical therapeutic agent with satisfactory antibacterial properties. It is poorly absorbed from the gastrointestinal tract and is used as a luminal amebicide. It acts by chelation of ferrous ions essential for metabolism. It is active against both cyst and trophozoites that are localized in the lumen of the intestine. It is used in the treatment of amoebiasis. It is considered the drug of choice for treating asymptomatic or moderate forms of amebiasis. It was discovered by Adco Co.
Purity:
98%
Appearance:
Yellow to Tan Powder or Crystals
Synonyms:
Iodoquinol;5,7-diiodoquinolin-8-ol;5,7-Diiodo-8-hydroxyquinoline;Diiodohydroxyquinoline;Diiodohydroxyquinoline
Solubility:
10 mM in DMSO
Storage:
-20°C Freezer
MSDS:
Inquire
Application:
5,7-Diiodo-8-Quinolinol is active against both cyst and trophozoites that are localized in the lumen of the intestine. It is used in the treatment of amoebiasis. It is considered the drug of choice for treating asymptomatic or moderate forms of amebiasis.
Quality Standard:
USP standard
Shelf Life:
2 month in rt, long time
Quantity:
Kilogram to ton
Boiling Point:
401.8±45.0 °C | Condition: Press: 760 Torr
Melting Point:
210 °C
Density:
2.491±0.06 g/cm3 | Condition: Temp: 20 °C Press: 760 Torr
InChIKey:
UXZFQZANDVDGMM-UHFFFAOYSA-N
InChI:
InChI=1S/C9H5I2NO/c10-6-4-7(11)9(13)8-5(6)2-1-3-12-8/h1-4,13H
Canonical SMILES:
C1=CC2=C(C(=C(C=C2I)I)O)N=C1
Current Developer:
5,7-Diiodo-8-Quinolinol was discovered by Adco Co.
1.Oral treatment of acrodermatitis enteropathica with zinc sulfate.
Der Kaloustian VM;Musallam SS;Sanjad SA;Murib A;Hammad WD;Idriss ZH Am J Dis Child. 1976 Apr;130(4):421-3.
In a 7-year-old boy with acrodermatitis enteropathica, oral administration of zinc sulfate brought about complete relief of symptoms and signs, with clearing of the skin lesions, arrest of diarrhea, and growth of new hair. Considering the dramatic results obtained, we believe that oral treatment with zinc sulfate is an innocuous, inexpensive, and very effective medication for acrodermatitis enteropathica, which can replace the previously used and toxic diiodohydroxyquin-like drugs.
2.Treatment of acrodermatitis enteropathica with zinc sulfate.
Campo AG Jr;McDonald CJ Arch Dermatol. 1976 May;112(5):687-9.
Control of a case of acrodermatitis enteropathica was achieved initially after three months of treatment with diiodohydroxyquin (Diodoquin). Reexacerbation of acrodermatitis enteropathica was noted two months after diiodohydroxyquin was discontinued. Treatment with zinc sulfate was substituted and resulted in dramatic and complete resolution of disease within 48 hours.
3.A review of the clinical presentation of dientamoebiasis.
Stark D;Barratt J;Roberts T;Marriott D;Harkness J;Ellis J Am J Trop Med Hyg. 2010 Apr;82(4):614-9. doi: 10.4269/ajtmh.2010.09-0478.
Among 750 symptomatic and asymptomatic patients, Dientamoeba fragilis was detected at a prevalence of 5.2% and more common than Giardia intestinalis. Most infected patients presented with diarrhea and abdominal pain with symptoms greater than 2 weeks duration being common. Bacterial and viral causes of infection were excluded by routine microbiological techniques. Treatment of D. fragilis infection with either iodoquinol, paromomycin, or combination therapy resulted in the eradication of the parasite and complete resolution of symptoms. Treatment failure/relapses were associated only with the use of metronidazole. Nineteen patients were examined for pin worm, no Enterobius vermicularis, a proposed vector of transmission, were detected. Intermittent shedding of D. fragilis was found to be highly variable. These studies confirm the pathogenic nature of D. fragilis and we recommend laboratories routinely test for the organism.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Products


CAS 109552-15-0 Pamidronate disodium pentahydrate

Pamidronate disodium pentahydrate
(CAS: 109552-15-0)

Pamidronate disodium pentahydrate is a nitrogen-containing bisphosphonate, used to prevent osteoporosis.

CAS 18642-23-4 Psoralidin

Psoralidin
(CAS: 18642-23-4)

Psoralidin is a furanocoumarin natural product used in Chinese medicine. Psoralidin, a PTP1B inhibitor, has been shown to have anticancer activity with a variet...

CAS 269730-03-2 RPI-1

RPI-1
(CAS: 269730-03-2)

RPI-1 is a cell-permeable, ATP-dependent RET kinase inhibitor. Oral treatment with RPI-1 caused growth arrest or regression in 81% treated tumors. It can also b...

CAS 1217201-17-6 A 350619 hydrochloride

A 350619 hydrochloride
(CAS: 1217201-17-6)

A 350619 hydrochloride is an activator of soluble guanylyl cyclase (sGC) that stimulates basal sGC and synergistically activates sGC in the presence of NO. It i...

NSC-601980 analog
(CAS: 91757-46-9)

NSC-601980 analog is the analog of the NSC601980, which shows antitumor activity in the yeast screening experiment.

CAS 1093069-32-9 JNJ-39327041

JNJ-39327041
(CAS: 1093069-32-9)

JNJ-39327041 is a bio-active chemical compound.

CAS 107-41-5 2-Methyl-2,4-pentanediol

2-Methyl-2,4-pentanediol
(CAS: 107-41-5)

2-Methyl-2,4-pentanediol, an analog of hexylene glycol, is a small molecular surfactant which could be useful as an environmentally friendly industrial coating ...

CAS 150113-99-8 Decanoyl-RVKR-CMK

Decanoyl-RVKR-CMK
(CAS: 150113-99-8)

Decanoyl-RVKR-CMK is a proprotein convertase inhibitor and has been found to restrain regulated secretion of the neuronal polypeptide VGF in PC12 cells.

Chemical Structure

CAS 83-73-8 5,7-Diiodo-8-Quinolinol

Quick Inquiry

Verification code

Featured Items